KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Abbott Laboratories (ABT) Income from Continuing Operations (2016 - 2026)

Abbott Laboratories' Income from Continuing Operations history spans 18 years, with the latest figure at 1077000000.0 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations fell 18.72% to 1077000000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 6276000000.0, a 53.52% decrease, with the full-year FY2025 number at 6524000000.0, down 51.32% from a year prior.
  • Income from Continuing Operations hit 1077000000.0 in Q1 2026 for Abbott Laboratories, down from 1776000000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for ABT hit a ceiling of 9229000000.0 in Q4 2024 and a floor of 1033000000.0 in Q4 2022.
  • Historically, Income from Continuing Operations has averaged 1979941176.47 across 5 years, with a median of 1436000000.0 in 2023.
  • Biggest five-year swings in Income from Continuing Operations: soared 478.98% in 2024 and later crashed 80.76% in 2025.
  • Tracing ABT's Income from Continuing Operations over 5 years: stood at 1033000000.0 in 2022, then surged by 54.31% to 1594000000.0 in 2023, then soared by 478.98% to 9229000000.0 in 2024, then crashed by 80.76% to 1776000000.0 in 2025, then crashed by 39.36% to 1077000000.0 in 2026.
  • Business Quant data shows Income from Continuing Operations for ABT at 1077000000.0 in Q1 2026, 1776000000.0 in Q4 2025, and 1644000000.0 in Q3 2025.